A cross-sectional study of the magnitude, barriers, and outcomes of HIV status disclosure among women participating in a perinatal HIV transmission study, "the Nevirapine Repeat Pregnancy study"

被引:8
作者
Kiweewa, Flavia M. [1 ,4 ]
Bakaki, Paul M. [2 ]
McConnell, Michelle S. [3 ]
Musisi, Maria [1 ]
Namirembe, Constance [1 ]
Nakayiwa, Frances [1 ]
Kusasira, Fiona [1 ]
Nakintu, Dorothy [1 ]
Mubiru, Michael C. [1 ]
Musoke, Philippa [1 ,5 ]
Fowler, Mary Glenn [6 ]
机构
[1] Makerere Univ Johns Hopkins Univ MU JHU Res Colla, Kampala, Uganda
[2] Case Western Reserve Univ, Cleveland, OH 44106 USA
[3] Ctr Dis Control & Prevent, US Dept HHS, Hanoi, Vietnam
[4] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda
[5] Makerere Univ, Univ Coll Hlth Sci, Sch Med, Dept Pediat & Child Hlth, Makerere, Uganda
[6] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
关键词
HIV status; Disclosure; Perinatal; Mother-to-child; Partner; TO-CHILD TRANSMISSION; SINGLE-DOSE NEVIRAPINE; DAR-ES-SALAAM; ANTIRETROVIRAL THERAPY; SEROSTATUS DISCLOSURE; SEXUAL PARTNERS; PREVENTION; ZIDOVUDINE; HIV/AIDS; INFECTION;
D O I
10.1186/s12889-015-2345-6
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: HIV status disclosure is a difficult emotional task for HIV-infected persons and may create the opportunity for both social support and rejection. In this study, we evaluated the proportions, patterns, barriers and outcomes of HIV-1 status disclosure among a group of women in Uganda. Methods: An exit interview was conducted one year post-partum for 85 HIV-infected women who participated in a study of HIV-1 transmission rates among NVP-experienced compared with NVP-naive women in "The Nevirapine Repeat Pregnancy (NVP-RP) Study" at the Makerere University-Johns Hopkins University Research Collaboration, Kampala-Uganda, between June 2004 and June 2006. Results: Of the 85 women interviewed, 99 % had disclosed their HIV status to at least one other person. Disclosure proportions ranged between 1 % to employer(s) and 69 % to a relative other than a parent. Only 38 % of the women had disclosed to their sex partners. Women with an HIV-infected baby were more likely than those with an uninfected baby to disclose to their sex partner, OR 4.9 (95 % CI, 2.0-11.2), and women were less likely to disclose to a partner if they had previously disclosed to another relative than if they had not, OR 0.19 (95 % CI, 0.14-0.52). The most common reasons for non-disclosure included fear of separation from the partner and subsequent loss of financial support 34 %, and not living with the partner (not having opportunities to disclose) 26 %. While most women (67 %) reported getting social support following disclosure, 22 % reported negative outcomes (neglect, separation from their partners, and loss of financial support). Following disclosure of HIV status, 9 % of women reported that their partner (s) decided to have an HIV test. Conclusion: Results from this study show high overall HIV disclosure proportions and how this disclosure of HIV status can foster social support. However, proportions of disclosure specifically to male sex partners were low, which suggests the need for interventions aimed at increasing male involvement in perinatal care, along with supportive counseling.
引用
收藏
页数:7
相关论文
共 39 条
[1]  
Aluisio A., 2010, J Acquir Immune Defic Syndr, V56, P76
[2]   Predictors of HIV-1 serostatus disclosure: a prospective study among HIV-infected pregnant women in Dar es Salaam, Tanzania [J].
Antelman, G ;
Fawzi, MCS ;
Kaaya, S ;
Mbwambo, J ;
Msamanga, GI ;
Hunter, DJ ;
Fawzi, WW .
AIDS, 2001, 15 (14) :1865-1874
[3]   Factors correlated with disclosure of HIV infection in the French Antilles and French Guiana: results from the ANRS-EN13-VESPA-DFA Study [J].
Bouillon, Kim ;
Lert, France ;
Sitta, Remi ;
Schmaus, Annie ;
Spire, Bruno ;
Dray-Spira, Rosemary .
AIDS, 2007, 21 :S89-S94
[4]   When do HIV-Infected women disclose their HIV status to their male partner and why? A study in a PMTCT programme, Abidjan [J].
Brou, Hermann ;
Djohan, Gerard ;
Becquet, Renaud ;
Allou, Gerard ;
Ekouevi, Didier K. ;
Viho, Ida ;
Leroy, Valeriane ;
Desgrees-du-Lou, Annabel .
PLOS MEDICINE, 2007, 4 (12) :1912-1920
[5]  
Centers for Disease Control and Prevention, HIV TEST COUNS PROT
[6]   Maternal or Infant Antiretroviral Drugs to Reduce HIV-1 Transmission [J].
Chasela, Charles S. ;
Hudgens, Michael G. ;
Jamieson, Denise J. ;
Kayira, Dumbani ;
Hosseinipour, Mina C. ;
Kourtis, Athena P. ;
Martinson, Francis ;
Tegha, Gerald ;
Knight, Rodney J. ;
Ahmed, Yusuf I. ;
Kamwendo, Deborah D. ;
Hoffman, Irving F. ;
Ellington, Sascha R. ;
Kacheche, Zebrone ;
Soko, Alice ;
Wiener, Jeffrey B. ;
Fiscus, Susan A. ;
Kazembe, Peter ;
Mofolo, Innocent A. ;
Chigwenembe, Maggie ;
Sichali, Dorothy S. ;
van der Horst, Charles M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (24) :2271-2281
[7]   The prevention of mother-to-child HIV transmission programme in Lilongwe, Malawi: why do so many women drop out [J].
Chinkonde, Jacqueline Rose ;
Sundby, Johanne ;
Martinson, Francis .
REPRODUCTIVE HEALTH MATTERS, 2009, 17 (33) :143-151
[8]   REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT [J].
CONNOR, EM ;
SPERLING, RS ;
GELBER, R ;
KISELEV, P ;
SCOTT, G ;
OSULLIVAN, MJ ;
VANDYKE, R ;
BEY, M ;
SHEARER, W ;
JACOBSON, RL ;
JIMENEZ, E ;
ONEILL, E ;
BAZIN, B ;
DELFRAISSY, JF ;
CULNANE, M ;
COOMBS, R ;
ELKINS, M ;
MOYE, J ;
STRATTON, P ;
BALSLEY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1173-1180
[9]   HIV-1 Prevention for HIV-1 Serodiscordant Couples [J].
Curran, Kathryn ;
Baeten, Jared M. ;
Coates, Thomas J. ;
Kurth, Ann ;
Mugo, Nelly R. ;
Celum, Connie .
CURRENT HIV/AIDS REPORTS, 2012, 9 (02) :160-170
[10]  
Dabis F, 2005, AIDS, V19, P309